PharmaOzempic maker Novo Nordisk has an experimental anti-obesity pill with noteworthy early trial resultsBy Bruce Gil and Andy MillsPublished September 11, 2024Share to TwitterShare to FacebookShare to RedditShare to EmailShare to Link📬 Sign up for the Daily BriefOur free, fast and fun briefing on the global economy, delivered every weekday morning.Sign me up
